This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jerry H. Gurwitz, MD
Boston, Mass

Arch Intern Med. 1995;155(18):2017-2018.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I read with interest the review article by Yeager et al¹ on the management of the behavioral manifestations of dementia. The article included a treatment algorithm suggesting a management strategy for the demented patient with aberrant behavior. The algorithm appropriately emphasized nonpharmacologic approaches as the optimal initial management strategy for these patients. For the patient who is unresponsive to nonpharmacologic measures, the algorithm recommended the initiation of a trial of antipsychotic therapy for 8 weeks. The suggested regimens include haloperidol, 2.5 mg at bedtime, or thioridazine, 25 mg at bedtime, with titration of these doses according to the patient's response to therapy. Buried in the legend of the figure describing the treatment algorithm was a recommendation that a lower starting dose is recommended in the elderly. However, no dosing recommendations were given and the less-than-careful reader could easily miss this important warning. Since the elderly constitute the vast majority . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?